Guideline

These guidelines contain policy recommendations on priority areas in the treatment of drug-susceptible TB and patient care.

The goal of this document is to provide practical answers to ethical questions in regard to the End TB Strategy.

This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.

This guideline outlines the steps involved in conducting a TB interview for a contact investigation.

This guideline presents information about the prevention of TB in health care facilities.

These guidelines are designed to aid central units of national TB and HIV/AIDS programs work with districts to implement collaborative TB/HIV activities.

These guidelines offer recommendations for TB control programmes and medical workers in middle- and low- income countries faced with drug-resistant forms of TB, especially MDR-TB.

The revised guidelines address the concerns about transmission of TB
during air travel and provide the following: (i) information on transmission
of TB on aircraft; (ii) a summary of the practices adopted for the
management of patients with infectious TB associated with air travel,
and of commonly encountered diffi culties; (iii) suggestions on practical
ways to reduce the risk of exposure to M. tuberculosis on board commercial
aircraft, and (iv) guidance on procedures to follow and responsibilities

Addendum to WHO "Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-Limited Settings, 1999"
The goal of this addendum is to help management and staff minimize the risk of TB transmission at facilities in resource-limited settings in which HIV-infected persons receive diagnosis, care, treatment, and/or support, and settings in which there is a high prevalence of HIV infection, both known and undiagnosed.

This document guides NTPs on how to engage all relevant health care providers in TB control and thereby promote the use of evidence-based, International Standards for TB Care. The experience and evidence on scaling up and sustaining PPM is now clearly emerging. The authors hope that this document will help countries to scale up PPM DOTS more rapidly and contribute significantly to achieving the TB-related Millennium Development Goal.